News
The integration of Artificial Intelligence (AI) in various sectors has been nothing short of transformative, and now, it’s poised to ...
The Odessa American is the leading source of local news, information, entertainment and sports for the Permian Basin.
The state is devoting $50 million to a research consortium looking into the effects of ibogaine, an illegal drug being touted ...
The Food and Drug Administration (FDA) is looking to AI to solve the problem of lengthy approval processes, as the Trump ...
The U.S. Food and Drug Administration (FDA) says it plans to use artificial intelligence (AI) to help speed the approval of ...
U.S. FDA successfully completed Pre-License Inspection; Company expects facility will meet all requirements to support ...
AMSTERDAM, June 11, 2025 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced the ...
OneSource Specialty Pharma partners with Swedish biotech company Xbrane, on its biosimilar portfolio
OneSource Specialty Pharma partners with Xbrane Biopharma for biosimilar manufacturing, aiming to strengthen global supply ...
The current contraceptive landscape places a disproportionate amount of physical and mental burden for pregnancy prevention ...
With a Trump-driven reduction of nearly 2,000 employees, agency officials view artificial intelligence as a way to speed ...
We recently wrote an introductory overview of navigating the Common Law Research Exemption and the Hatch-Waxman Safe Harbor ...
PDUFA date of June 13th 2025 by which FDA will decide upon whether or not UGN-102 should be approved for patients with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results